Half-Year 2022 Financial and Clinical Trials Update

Pathology Lab CER-Constant Exchange Rates CHF bn 0.8 2022 vs. 2021 CER growth +10% 0.6 0.4 0.2 0.0 HY 2020 HY 2021 Advanced Staining Primary Staining +26% +2% +9% HY 2022 Companion Diagnostics Roche 194

View entire presentation